Sei Investments Co. raised its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 17.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 163,784 shares of the business services provider's stock after purchasing an additional 24,870 shares during the period. Sei Investments Co. owned 0.09% of Genpact worth $7,034,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. SRH Advisors LLC acquired a new position in Genpact in the fourth quarter valued at about $26,000. Manchester Capital Management LLC acquired a new stake in shares of Genpact in the 4th quarter valued at approximately $38,000. Smartleaf Asset Management LLC boosted its stake in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after acquiring an additional 783 shares during the last quarter. UMB Bank n.a. boosted its stake in Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after acquiring an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp grew its holdings in Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock valued at $69,000 after purchasing an additional 453 shares during the period. Institutional investors own 96.03% of the company's stock.
Genpact Stock Performance
NYSE G traded down $1.83 during trading on Friday, reaching $47.08. 2,182,743 shares of the company's stock were exchanged, compared to its average volume of 1,347,002. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a market capitalization of $8.27 billion, a P/E ratio of 16.58, a PEG ratio of 1.84 and a beta of 1.06. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The business has a 50 day moving average price of $51.20 and a 200-day moving average price of $45.39.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend was Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is presently 23.94%.
Insider Transactions at Genpact
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on G shares. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC increased their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Finally, Mizuho lifted their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $48.44.
Check Out Our Latest Stock Report on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.